COMMONS

Matt Hancock MP questioned on no-deal Brexit on health sector

22 October 2018

The Health and Social Care Committee hears from Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care, and academics, on likely impact of a no-deal Brexit on the health and social care sector.

Witnesses

Tuesday 23 October in Committee Room 6, Palaces of Westminster 

At 2.30pm 

  • Martin Sawer, Executive Director, Healthcare Distribution Association
  • Saffron Cordery, Deputy Chief Executive, NHS Providers
  • Mike Thompson, Chief Executive, Association of British Pharmaceutical Industry
  • Professor Tamara Hervey, Jean Monnet Professor of European Union Law, University of Sheffield
  • Mark Lloyd Davies, Senior Director, Medical Devices and Consumer Medical Technologies, Europe, Middle East and Africa, Johnson & Johnson

At 3.30pm

  • Rt Hon Matt Hancock MP, Secretary of State for Health and Social Care
  • Sir Chris Wormald, Permanent Secretary, Department of Health and Social Care

Purpose of the session

The Committee hears from the Secretary of State for Health and Social Care, academics and representatives from the NHS and the life science sectors on the likely impact of a no-deal Brexit on the health and social care sector, along with the key risks to patients, health and care services and companies. The Committee will also hear evidence on the effectiveness of planning by the Government and stakeholders for a no-deal scenario.

Further information

Image: iStockphoto

Share this page